Esketamine comes with close supervision requirements. 800 clinics have already been approved and dispensed initial applications.
FDA granted final approval to drug originally tentatively approved in 2018.
The FDA has recently approved new dosage form and two new indications for the drug.
Erdafitinib is first targeted therapy for FGFR3 or FGFR2 genetic alteration.
Safety alert issued requiring warning about concurrent alcohol use.
Women no longer require nine months of contraception post cessation of the drug.
First-ever dual-drug, single tablet for HIV offers lighter treatment regimen.
Image Credit: Cancer Health
The FDA has extended the indication for breast cancer drug Ibrance (palbociclib) to male patients.
Solriamfetol is approved for adult patients suffering from the effects of narcolepsy and OSA.
The next-generation oral drug is the first to be approved specifically for secondary progressive multiple sclerosis in more than 15 years.